Business Context and Reporting Period
Company: Rockwell Medical, Inc. (RMTI)
Filing Type: Form 8-K (Current Report)
Date of Report: July 20, 2026
Reporting Period: Event occurred on July 16, 2026, reported on July 20, 2026.
Key Financial Metrics
This filing is a current report regarding a corporate event and does not contain financial statements. The filing text does not provide values for revenue, profit, cash flow, margins, debt, or liquidity.
Material Changes
The material change reported is the resolution of a listing compliance issue:
- On July 16, 2026, the Company received written notification from the Nasdaq Listing Qualifications Staff.
- The Company has regained compliance with the minimum $1.00 per share bid price requirement (Nasdaq Listing Rule 5550(a)(2)).
- Nasdaq has officially closed the compliance matter.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, or outlook. No new risks or contingencies are disclosed in this specific report, other than the historical context of the prior non-compliance which has now been resolved.
Investor Verification Checklist
- Verify the current trading price of RMTI on the Nasdaq Capital Market to confirm sustained compliance above the $1.00 threshold.
- Review the attached press release (Exhibit 99.1) for any additional operational context regarding the stock price recovery.
- Confirm that no other pending Nasdaq compliance notices exist for the Company.